From: Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
 | HR | 95% CI | P |
---|---|---|---|
Univariate analysis | |||
 Age, per year | 1.003 | 0.977 – 1.029 | 0.840 |
 Gender, Male = 1 | 0.438 | 0.205 – 0.936 | 0.033 |
 Anti-HCV, positive = 1 | 1.277 | 0.540 – 3.021 | 0.578 |
 HBsAg, positive = 1 | 0.501 | 0.232 – 1.081 | 0.078 |
 Liver cirrhosis, yes = 1 | 1.112 | 0.522 – 2.366 | 0.783 |
 Microvascular invasion, yes = 1 | 1.775 | 0.812 – 3.884 | 0.151 |
 Macrovascular invasion, yes = 1 | 1.385 | 0.327 – 5.870 | 0.659 |
 Histology grade, per grade | 0.837 | 0.461 – 1.521 | 0.560 |
 Capsule, yes = 1 | 0.974 | 0.411 – 2.309 | 0.953 |
 Tumor number, per number | 0.998 | 0.653 – 1.525 | 0.994 |
 Ascites yes = 1 | 3.198 | 0.960 – 10.654 | 0.058 |
 Alcoholism yes = 1 | 1.386 | 0.606 – 3.171 | 0.440 |
 Largest tumor size, per cm | 1.077 | 0.994 – 1.168 | 0.071 |
 AFP, per 1000 ng/mL | 1.002 | 0.998 – 1.006 | 0.346 |
 Albumin, per g/L | 0.441 | 0.208 – 0.937 | 0.033 |
 Bilirubin, per mg/dL | 1.725 | 1.086 – 2.740 | 0.021 |
 PT, per sec | 0.695 | 0.374 – 1.293 | 0.251 |
 Creatinine, per mg/dL | 0.967 | 0.709 – 1.320 | 0.834 |
 AST, per U/L | 1.003 | 0.999 – 1.006 | 0.193 |
 ALT, per U/L | 1.000 | 0.995 – 1.005 | 0.997 |
Multivariate analysis | |||
 Gender, Male = 1 | 0.441 | 0.201 – 0.971 | 0.042 |
 Albumin, per g/dL | 0.560 | 0.270 – 1.160 | 0.119 |
 Bilirubin, per mg/dL | 1.802 | 1.131 – 2.870 | 0.013 |